"Zimbabwe Pharmaceuticals & Healthcare Report Q3 2013" Now Available at Fast Market Research
We do not expect any improvements in the way of the operating environment for pharmaceutical industry players in Zimbabwe, especially as the political situation remains tense in the runup to the elections. Although a Japanese drugmaker announced it will build a manufacturing facility in the country, we see this as an isolated example of foreign direct investment (FDI) into Zimbabwe, on account of an overwhelmingly negative business situation. We continue to envisage a continuation of medicine shortages, especially as local...
View full press release